Casdozokitug
- Generic Name
- Casdozokitug
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2643331-37-5
- Unique Ingredient Identifier
- AL6I5N2HTN
- Associated Conditions
- -
- Associated Therapies
- -
Coherus To Present Final Phase 2 Data On Casdozokitug In Liver Cancer Next Month
Coherus BioSciences to present final phase II study data of Casdozokitug with Atezolizumab and Bevacizumab for hepatocellular carcinoma at 2025 ASCO GI Annual Meeting. Interim results showed 38% objective response rate and over 60% tumor shrinkage. Another phase II study with bevacizumab and toripalimab is ongoing.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath